Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Hormel Foods Corporation's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $11.5B | |
|---|---|---|
| Revenue (ttm) | 12.1B | |
| Net income (ttm) | 342.7M | |
| EPS (ttm) | $0.62 | |
| Shares out | 550.4M | |
| P/E (trailing) | 33.2x | |
| P/E (forward) | 13.4x | |
| Dividend | $1.17 (5.68%) | |
| Volume | 2,117,989 | |
| Beta | 0.29 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-10-31 | 2022-10-30 | 2023-10-29 | 2024-10-27 | 2025-10-26 | Trend |
| Revenue | $11.39B | $12.46B | $12.11B | $11.92B | $12.11B | +1.5% |
| Gross profit | $1.93B | $2.16B | $2.00B | $2.02B | $1.89B | -0.5% |
| Operating income | $1.12B | $1.31B | $1.07B | $1.07B | $718.6M | -10.6% |
| Net income | $908.8M | $1,000.0M | $793.6M | $805.0M | $478.2M | -14.8% |
| EPS (diluted) | $1.66 | $1.82 | $1.45 | $1.47 | $0.87 | -14.9% |
| EBITDA | $1.38B | $1.58B | $1.34B | $1.37B | $1.01B | -7.6% |
| R&D | $33.6M | $34.7M | $33.7M | $36.1M | $35.2M | +1.2% |
| SG&A | $853.1M | $879.3M | $942.2M | $1.01B | $996.6M | +4.0% |
Recent company headlines from major financial publishers.
Gradual operating margin normalization from FY2025 trough toward historical levels supports dividend stability and steady cash flow expansion, delivering target $23.82 with probability 60.0% and return 14.4%. Disconfirmation would occur by FY2026 if operating margin fails to rebound or free cash flow remains below dividend payouts.
Foodservice expansion accelerates alongside input cost deflation across turkey and pork, lifting gross margins and driving operating margin recovery beyond historical baselines. This path reaches target $38.24 with probability 20.0% and return 83.6%. Disconfirmation would appear by FY2026 if wholesale protein costs spike again or restaurant foot traffic stalls.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.5% | $29.5 | $32.9 | $37.8 | $45.5 | $59.8 |
| 5.4% | $24.5 | $26.4 | $28.8 | $32.2 | $37.2 |
| 6.4% | $21.3 | $22.4 | $23.8 | $25.8 | $28.2 |
| 7.3% | $19.0 | $19.8 | $20.7 | $21.9 | $23.4 |
| 8.2% | $17.3 | $17.8 | $18.5 | $19.3 | $20.2 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
